Cayir, A <br/><br/>
The lung endothelin system: a potent therapeutic target with bosentan for the amelioration of lung alterations in a rat model of diabetes mellitus.  [electronic resource] 

 -  Journal of endocrinological investigation  Sep 2015 
 - 987-98 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1720-8386 
<br/><br/><label>Standard No.: </label>10.1007/s40618-015-0282-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Lung Injury--drug therapy<br/>Animals<br/>Bosentan<br/>Diabetes Mellitus, Experimental--complications<br/>Endothelin Receptor Antagonists--pharmacology<br/>Glutathione--metabolism<br/>Lung--drug effects<br/>Male<br/>Malondialdehyde--metabolism<br/>Oxidative Stress--drug effects<br/>Rats<br/>Rats, Wistar<br/>Sulfonamides--pharmacology<br/>Superoxide Dismutase--metabolism<br/>Transforming Growth Factor beta--metabolism<br/>Tumor Necrosis Factor-alpha--metabolism